China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.218
-0.024 (-9.91%)
At close: Jan 31, 2025, 3:42 PM
0.214
-0.004 (-1.92%)
After-hours: Jan 31, 2025, 7:54 PM EST
China Pharma Holdings Market Cap
China Pharma Holdings has a market cap or net worth of $4.20 million as of January 31, 2025. Its market cap has increased by 31.34% in one year.
Market Cap
4.20M
Enterprise Value
7.50M
1-Year Change
31.34%
Ranking
Category
Stock Price
$0.22
Market Cap Chart
Since May 16, 2002, China Pharma Holdings's market cap has decreased from $526.80M to $4.20M, a decrease of -99.20%. That is a compound annual growth rate of -19.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 4.20M | -6.67% |
| Dec 31, 2024 | 4.50M | 12.50% |
| Dec 29, 2023 | 4.00M | -20.00% |
| Dec 30, 2022 | 5.00M | -78.07% |
| Dec 31, 2021 | 22.80M | 17.53% |
| Dec 31, 2020 | 19.40M | 88.35% |
| Dec 31, 2019 | 10.30M | -8.04% |
| Dec 31, 2018 | 11.20M | 45.45% |
| Dec 29, 2017 | 7.70M | -31.86% |
| Dec 30, 2016 | 11.30M | 66.18% |
| Dec 31, 2015 | 6.80M | -48.09% |
| Dec 31, 2014 | 13.10M | -12.67% |
| Dec 31, 2013 | 15.00M | 70.45% |
| Dec 31, 2012 | 8.80M | -69.86% |
| Dec 30, 2011 | 29.20M | -77.79% |
| Dec 31, 2010 | 131.50M | -19.23% |
| Dec 31, 2009 | 162.80M | 237.76% |
| Dec 31, 2008 | 48.20M | -91.78% |
| Dec 29, 2006 | 586.10M | 26.10% |
| Dec 30, 2005 | 464.80M | 2,145.41% |
| Dec 31, 2004 | 20.70M | -86.64% |
| Dec 31, 2003 | 154.90M | 25.02% |
| Dec 31, 2002 | 123.90M | -76.48% |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.02B |
| UnitedHealth Group | 495.21B |
| Novo Nordisk | 376.62B |
| Johnson & Johnson | 363.91B |
| AbbVie | 309.71B |
| Merck & Co. | 248.61B |
| Abbott Laboratories | 221.77B |
| Thermo Fisher Scientific | 217.35B |